Ellsworth Advisors’s Eli Lilly LLY Stock Holding History

Ellsworth Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.6M	Sell	4,841 -4,596	-49%	-$4.7M	0.92%	46
2026 Q1	$8.68M	Buy	9,437 +4,955	+111%	+$5.02M	1.63%	13
2025 Q4	$4.63M	Buy	4,482 +181	+4%	+$173K	0.92%	45
2025 Q3	$3.56M	Buy	4,301 +1,719	+67%	+$1.28M	0.76%	47
2025 Q2	$2.01M	Buy	2,582 +250	+11%	+$194K	0.49%	64
2025 Q1	$1.93M	Buy	2,332 +130	+6%	+$108K	0.51%	64
2024 Q4	$1.7M	Buy	2,202 +1,806	+456%	+$1.5M	0.45%	71
2024 Q3	$351K	Buy	396 +8	+2%	+$7.19K	0.09%	152
2024 Q2	$352K	Sell	388 -10	-3%	-$8K	0.1%	151
2024 Q1	$299K	Buy	398 +5	+1%	+$3.56K	0.09%	152
2023 Q4	$229K	Sell	393 -2	-0.5%	-$1.17K	0.07%	157
2023 Q3	$234K	Buy	+395	New	+$204K	0.08%	153

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ellsworth Advisors's LLY Position: Q2 2026 in Review

Ellsworth Advisors reduced its Eli Lilly (LLY) stake by 49% in Q2 2026, selling an estimated $4.7M and leaving 4,841 shares worth $5.6M. The position accounts for 0.92% of the portfolio, ranked #46.

Ellsworth Advisors first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.68M in Q1 2026. 1,564 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Ellsworth Advisors held 4,841 shares of Eli Lilly worth $5.6M as of Q2 2026.
Ellsworth Advisors sold 4,596 Eli Lilly shares in Q2 2026, an estimated $4.7M.
Eli Lilly made up 0.92% of Ellsworth Advisors's portfolio in Q2 2026, its #46 holding.
Ellsworth Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
Ellsworth Advisors's Eli Lilly position peaked at $8.68M in Q1 2026.
1,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.